Navidea receives NIH grant, enters into agreement with Siemens' PETNET Solutions for imaging agent Aug. 22, 2013 No Comments
Memorial Sloan-Kettering Cancer Center begins phase I trial of radiolabeled dasatinib derivative Aug. 22, 2013 No Comments
Phase II trial finds fluorescein an alternative for SLN identification in melanoma Aug. 14, 2013 No Comments
Researchers present phase III results for 99mTc tilmanocept in melanoma patients Aug. 14, 2013 No Comments
RSS